Most common are GI: nausea, decreased appetite, constipation, occasional diarrhea, and reflux typically mild to moderate and concentrated during dose escalation
Decitabine, an analog of 5-azacytidine, is also a potent DNMT1 inhibitor with a more favorable safety profile but decitabine is rapidly deaminated and inactivated by cytosine deaminase, if taken orally
Ci 77891 is commonly found in sunscreens due to its ability to block UV rays
Insurance Coverage Insurance coverage for weight loss medications varies significantly by plan
Compare the PlexusDx approach: see the Weight Management Protocols semaglutide and tirzepatide with the genetic context most providers don't offer
Michigan, Rhode Island, and Wisconsin are planning or considering restrictions, according to KFFs most recent survey